AKINETON

Main information

  • Trade name:
  • AKINETON 2 mg tablet
  • Dosage:
  • 2 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • AKINETON 2 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Biperiden
  • Product summary:
  • ; Suitability for use in older adult patients Biperideni hydrochloridum Avoid using in older persons. Anticholinergic. Significant adverse effects include xerostomia, constipation, dizziness, tachycardia, urinary difficulties, confusion and cognitive disorder. Weakens the efficacy of anti-Alzheimer´s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 5413
  • Authorization date:
  • 11-06-2008
  • Last update:
  • 26-07-2018